Does anyone understand any of it?
Well I think I understand what they are saying but I don't understand why they would do such a study or why they think it means anything, or why the journal published it.
Earlier in this thread people seemed to think the authors were saying that these SNPs were peculiar to NK cells but that is not so. They just chose to look in NK cells for this particular study.
Previously they had looked at similar SNPs in mononuclear cells (PBMNCs; the study referred to by
@Valentijn). That study is discussed, along with claims by the group to be developing a diagnostic test for CFS/ME, in
this thread.
In the NK study they have analysed a broader range of SNPs and have added an assay of NK cell function, but essentially it is just a repeat of the PBMNC study - very small number of subjects and the same dodgy statistics.
The expansion has enabled them to claim a publication rather than a letter to the editor which was all they could manage for the previous very thin study. This seems like an attempt to boost publication numbers.
Even if the numbers and statistics gave one more confidence in the study, it makes no sense to study SNPs in different cell populations and imply that their presence their has some implication for function.
The SNPs are genome-wide and would be found in any cell examined.
SNPs in ion-channels could well be a fruitful avenue of research in CFS/ME but the SNP studies by this group so far are abysmal.